Nathan J Dowden
COO, President at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $426K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 4SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 15,000198,588 held (−7%) | $15.33 | $230K | -71.5% |
| Mar 11SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 3,116210,482 held (−1%) | $13.02 | $41K | -66.4% |
| Mar 11SEC | TRDAEntrada Therapeutics, Inc. | Sell Plan | 11,894198,588 held (−6%) | $13.05 | $155K | -66.5% |
- Sell
COO, President Nathan J Dowden sold $230K of TRDA at $15.33 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Nathan J Dowden sold $41K of TRDA at $13.02 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Nathan J Dowden sold $155K of TRDA at $13.05 — pre-scheduled 10b5-1 plan sale.